Cleared Traditional

K950979 - HEP-2000 COLORZYME ANA-RO TEST SYSTEM

K950979 is the FDA 510(k) clearance for HEP-2000 COLORZYME ANA-RO TEST SYSTEM by Immuno Concepts, Inc.. It is a Class 2 Immunology device (product code DHN) cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K950979 · Immuno Concepts, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1995
Decision
90d
Days
Class 2
Risk

K950979 is an FDA 510(k) clearance for the HEP-2000 COLORZYME ANA-RO TEST SYSTEM. Classified as Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control (product code DHN), Class II - Special Controls.

Submitted by Immuno Concepts, Inc. (Irving, US). The FDA issued a Cleared decision on June 1, 1995 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Immuno Concepts, Inc. devices

Submission Details

510(k) Number K950979 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 03, 1995
Decision Date June 01, 1995
Days to Decision 90 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
14d faster than avg
Panel avg: 104d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control

All 51
Devices cleared under the same product code (DHN) and FDA review panel - the closest regulatory comparables to K950979.
LIQUICHEK ANA CONTROL, SPECKLED PATTERN, MODEL 202
K984400 · Bio-Rad · Dec 1998
HEP-2000 FLUORESCENT ANA-RO TEST SYSTEM
K972145 · Immuno Concepts, Inc. · Feb 1998
HEMAGEN ENA DSDNA KIT (EIA METHOD)
K962276 · Hemagen Diagnostics, Inc. · Dec 1996
HEP-2000 FLUORESCENT ANA-RO TEST SYSTEM
K944096 · Immuno Concepts, Inc. · Nov 1994
HEMAGEN ENA [JO-I] KIT
K902139 · Hemagen Diagnostics, Inc. · May 1990
NOVA LITE(TM) ANA KSL
K901596 · Inova Diagnostics, Inc. · May 1990